XML 61 R48.htm IDEA: XBRL DOCUMENT v3.19.1
Stockholders' Equity and Derivative Liability - Warrants - Common Stock and Warrant Offering (Details)
6 Months Ended 12 Months Ended
Jul. 03, 2018
USD ($)
$ / shares
Apr. 25, 2017
USD ($)
$ / shares
shares
Apr. 04, 2016
USD ($)
$ / shares
shares
Oct. 13, 2015
USD ($)
$ / shares
$ / item
shares
Dec. 31, 2017
USD ($)
$ / shares
shares
Dec. 31, 2018
USD ($)
$ / shares
Dec. 31, 2017
USD ($)
$ / shares
Jun. 30, 2017
shares
Common Stock and Warrant Offering                
Underwriting discount and other offering expenses payable $ 900,000              
Derivative financial instruments liability - warrants         $ 669,462 $ 404,337 $ 669,462  
Level 3 | Warrants                
Common Stock and Warrant Offering                
Derivative financial instruments liability - warrants         $ 700,000 $ 400,000 $ 700,000  
Over-Allotment Option                
Common Stock and Warrant Offering                
Price of ContraVir common stock | $ / shares $ 1.71              
October 13 2015                
Common Stock and Warrant Offering                
Sale of shares (in shares) | shares       625,000        
Fixed combined price (in dollars per share) | $ / shares       $ 24.00        
Gross proceeds       $ 15,000,000        
Underwriting discount and other offering expenses payable       1,500,000        
Additional proceeds if warrants exercised in full       $ 12,800,000        
Price of ContraVir common stock | $ / shares         $ 2.88 $ 0.28 $ 2.88  
Expected warrant term (years)           1 year 9 months 11 days 2 years 9 months 11 days  
Risk-free interest rate (as a percent)           2.48% 2.09%  
Expected volatility (as a percent)           74.00% 67.00%  
October 13 2015 | Warrants                
Common Stock and Warrant Offering                
Warrants issued (in shares) | shares       375,000        
Exercise period for warrants       5 years        
Exercise price of warrants (in dollars per share) | $ / shares       $ 34.00        
October 13 2015 | Level 3 | Warrants                
Common Stock and Warrant Offering                
Derivative financial instruments liability - warrants       $ 4,400,000        
October 13 2015 | Over-Allotment Option                
Common Stock and Warrant Offering                
Underwriter option period       45 days        
Authorized for sale (in shares) | shares       93,750        
Purchase price (in dollars per unit) | $ / item       24.00        
October 13 2015 | Over-Allotment Option | Warrants                
Common Stock and Warrant Offering                
Number of warrants offered for sale | shares       56,250        
April 4 2016                
Common Stock and Warrant Offering                
Sale of shares (in shares) | shares     616,197          
Fixed combined price (in dollars per share) | $ / shares     $ 11.36          
Gross proceeds     $ 7,000,000          
Underwriting discount and other offering expenses payable     700,000          
Additional proceeds if warrants exercised in full     $ 4,200,000          
Price of ContraVir common stock | $ / shares         2.88 $ 0.28 $ 2.88  
Expected warrant term (years)           2 years 3 months 4 days 3 years  
Risk-free interest rate (as a percent)           2.48% 2.09%  
Expected volatility (as a percent)           74.00% 67.00%  
April 4 2016 | Warrants                
Common Stock and Warrant Offering                
Warrants issued (in shares) | shares     308,098          
Exercise period for warrants     5 years          
Exercise price of warrants (in dollars per share) | $ / shares     $ 13.60          
April 4 2016 | Level 3 | Warrants                
Common Stock and Warrant Offering                
Derivative financial instruments liability - warrants     $ 1,500,000          
April 25 2017                
Common Stock and Warrant Offering                
Sale of shares (in shares) | shares   1,500,000            
Fixed combined price (in dollars per share) | $ / shares   $ 8.00            
Gross proceeds   $ 12,000,000            
Underwriting discount and other offering expenses payable   500,000            
Additional proceeds if warrants exercised in full   $ 7,500,000            
Price of ContraVir common stock | $ / shares         $ 2.88 $ 0.28 $ 2.88  
Expected warrant term (years)           3 years 3 months 22 days 4 years  
Risk-free interest rate (as a percent)           2.46% 2.09%  
Expected volatility (as a percent)           74.00% 68.00%  
April 25 2017 | Warrants                
Common Stock and Warrant Offering                
Warrants issued (in shares) | shares   750,000            
Exercise period for warrants   5 years            
Exercise price of warrants (in dollars per share) | $ / shares   $ 10.00            
April 25 2017 | Level 3 | Warrants                
Common Stock and Warrant Offering                
Derivative financial instruments liability - warrants   $ 4,000,000            
July 3 2018                
Common Stock and Warrant Offering                
Price of ContraVir common stock | $ / shares $ 1.36         $ 0.28    
Expected warrant term (years) 5 years         4 years 6 months    
Risk-free interest rate (as a percent) 2.72%         2.51%    
Expected volatility (as a percent) 75.00%         74.00%    
Common Stock                
Common Stock and Warrant Offering                
Sale of shares (in shares) | shares         329,078     2,305,235